Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Seminars in Hematology
Volume 44, Supplement 1, Pages 1-34 (January 2007)
Search Within This Issue
Integrating the New Generation of Targeted Therapies for Chronic Myelogenous Leukemia
Edited by H. Kantarjian

display abstract citation download email a colleague
Display:

free full text =free full text


Masthead free full text
page CO2
Full-Text PDF (32 KB)


Introduction
Elias Jabbour, Hagop Kantarjian
pages 1-3
Full Text | Full-Text PDF (81 KB)


The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy
Ricardo H. Alvarez, Hagop Kantarjian, Jorge E. Cortes
pages 4-14
Abstract | Full Text | Full-Text PDF (902 KB)


Resistance to Targeted Therapy in Chronic Myelogenous Leukemia
Andreas Hochhaus, Philipp Erben, Thomas Ernst, Martin C. Mueller
pages 15-24
Abstract | Full Text | Full-Text PDF (163 KB)


New Targeted Therapies for Chronic Myelogenous Leukemia: Opportunities to Overcome Imatinib Resistance
Elias Jabbour, Jorge Cortes, Susan O’Brien, Francis Giles, Hagop Kantarjian
pages 25-31
Abstract | Full Text | Full-Text PDF (128 KB)


Posttest
page 32
Full-Text PDF (44 KB)

Evaluation form (SCI-CML-0114)


Integrating the New Generation of Targeted Therapies for Chronic Myelogenous Leukemia: February 15, 2007
pages 33-34
Full-Text PDF (60 KB)

Frontmatter


Table of Contents free full text
page A1
Full-Text PDF (26 KB)


Supplement disclaimer free full text
page A2
Full-Text PDF (16 KB)

display abstract citation download email a colleague
Display:
Advertisement